Sanomachi, T., Suzuki, S., Togashi, K., Sugai, A., Seino, S., Okada, M., . . . Yamamoto, M. (2019). Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs. Cancers (Basel).
Citação norma ChicagoSanomachi, Tomomi, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Shizuka Seino, Masashi Okada, Takashi Yoshioka, Chifumi Kitanaka, and Masahiro Yamamoto. "Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs." Cancers (Basel) 2019.
ציטוט MLASanomachi, Tomomi, et al. "Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs." Cancers (Basel) 2019.